Hollander J E, Hoffman R S, Gennis P, Fairweather P, Feldman J A, Fish S S, DiSano M J, Schumb D A, Dyer S
Department of Emergency Medicine, University Hospital, State University of New York, Stony Brook 11794-7400, USA.
Acad Emerg Med. 1995 Mar;2(3):179-84. doi: 10.1111/j.1553-2712.1995.tb03191.x.
To determine the one-year mortality and incidence of myocardial infarction (MI) post-hospital discharge or ED release for patients with cocaine-associated chest pain.
A prospective, observational study of an inception cohort of consecutive patients who presented to one of four municipal hospital EDs with cocaine-associated chest pain. Patients were followed for one year from the end of the enrollment period. Main outcome parameters were the one-year actuarial survival and the frequency of nonfatal MI.
Mortality data were available for all 203 patients at a mean of 408 days. Additional clinical information was available for 185 patients (91%). There were six deaths (one-year actuarial survival 98%; 95% CI, 95-100%); none from MI. Nonfatal MI occurred in two patients (1%; 95% CI, 0-2%). Continued cocaine use was common (60%; 95% CI, 52-68%) and was associated with recurrent chest pain (75% vs 31%, p < 0.0001). No MI or death was reported for patients who claimed to have ceased cocaine use.
Patients who presented with cocaine-associated chest pain commonly continued to use cocaine after discharge. Urgent evaluation of coronary anatomy or cardiac stress tests may not be necessary for patients for whom MI is ruled out and who do not have recurrent potentially ischemic pain. The subsequent risk for MI and death in this group appears to be low. Intervention strategies should emphasize cessation of cocaine use.
确定可卡因相关性胸痛患者出院或急诊室出院后一年的死亡率及心肌梗死(MI)发生率。
对连续就诊于四家市级医院急诊室的可卡因相关性胸痛患者起始队列进行前瞻性观察研究。从入组期结束开始对患者进行为期一年的随访。主要结局参数为一年精算生存率和非致命性心肌梗死的发生率。
203例患者均有平均408天的死亡率数据。185例患者(91%)有额外的临床信息。有6例死亡(一年精算生存率98%;95%可信区间,95 - 100%);均非死于心肌梗死。2例患者发生非致命性心肌梗死(1%;95%可信区间,0 - 2%)。持续使用可卡因很常见(60%;95%可信区间,52 - 68%),且与复发性胸痛相关(75%对31%,p < 0.0001)。声称已停止使用可卡因的患者未报告发生心肌梗死或死亡。
出现可卡因相关性胸痛的患者出院后通常继续使用可卡因。对于排除心肌梗死且无复发性潜在缺血性疼痛的患者,可能无需紧急评估冠状动脉解剖结构或进行心脏负荷试验。该组患者随后发生心肌梗死和死亡的风险似乎较低。干预策略应强调停止使用可卡因。